ASP Isotopes Inc. (ASPI) has been approved for acquisition by Renergen Limited, with 99.80% of shareholders voting in favor at the July 10 meeting. The transaction is set to be finalized in Q3 2025 pending regulatory approvals and third-party consents by September 30, 2025.

Renergen, known for liquefied helium and natural gas production, is merging with ASP Isotopes to create a global leader in critical materials. The deal is projected to boost ASP Isotopes’ financials, with an estimated $300 million EBITDA by 2030, driven by isotopes, helium, and LNG sales in the South African energy market.

CEOs Stefano Marani and Paul Mann highlight the merger’s positive impact on supply chains for sectors like semiconductors and electronics, positioning the combined company as a strategic player in global supply chains. ASPI’s stock closed at $7.52 on Friday, up 1.08%, with after-hours trading at $7.42 on the NasdaqCM.

Read more at NASDAQ: ASP Isotopes Moves Forward With Renergen Acquisition After 99.8% Shareholder Approval